https://medicaldialogues.in/news/industry/pharma/astrazeneca-gets-cdsco-panel-nod-to-import-market-anti-diabetic-dapagliflozin-for-additional-indication-101171
0
0
10/23/22 at 6:00am
Organization
Medical Dialogues
Author
Medical Dialogues Team
31 words
0
Comments
New Delhi: Pharmaceutical major AstraZeneca has got a go-ahead from the Subject Expert Committee...
You are the first to view
Create an account
or login to join the discussion